Utility of Bacteriophages to Combat Drug Resistant Bacteria
  
Ambassador Deborah Birx, MD addresses the topic of bacteriophages, which are viruses capable of eliminating antibiotic-resistant bacteria. The existence of phages has been known for approximately 100 years. This therapy has been utilized in Eastern Europe for 20 to 30 years and represents established technology. Bacteriophages exhibit high specificity for their target bacteria, and unlike antibiotics, they do not disrupt the patient's microbiome. The discussion includes details on three Phase II clinical trials and outlines potential parameters for an upcoming Phase III clinical trial. The ongoing research focuses on infections caused by Pseudomonas and MRSA. In the future, phage therapy could potentially serve as either a standalone treatment or a complementary treatment alongside antibiotics for severe and resistant bacterial infections. This presentation was part of the Health Watch USA^sm meeting held on February 19, 2024. You Tube Video: https://youtu.be/_E02UFdca6g